(Q36577250)

15 August 2017

1 reference

title

Mechanisms of disease: mechanism-based classification of neuropathic pain-a critical analysis (English)

1 reference

15 August 2017

0 references

Nanna B Finnerup

1

0 references

Troels Staehelin Jensen

series ordinal

2

object named as

Troels S Jensen

1 reference

15 August 2017

1 February 2006

1 reference

Nature Clinical Practice Neurology

15 August 2017

1 reference

15 August 2017

2

1 reference

15 August 2017

2

1 reference

15 August 2017

107-115

1 reference

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

Systemic lidocaine in pain due to peripheral nerve injury and predictors of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

Lamotrigine for central poststroke pain: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

Effects of IV morphine in central pain: a randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolite levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Mechanisms of Disease: neuropathic pain—a clinical perspective

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Translation of symptoms and signs into mechanisms in neuropathic pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Symptoms and signs in patients with suspected neuropathic pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Development of a neuropathic pain questionnaire.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Development and validation of a brief, descriptive Danish pain questionnaire (BDDPQ).

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesion.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

The neurobiology of pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Molecular mechanisms of nociception

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Spinal cord glia: new players in pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Molecular mechanisms of cancer pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

1 reference

7 January 2021

The molecular dynamics of pain control

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

NK1 (substance P) receptor antagonists--why are they not analgesic in humans?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Dose-response study of the analgesic effect of lanepitant in patients with painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

The NK1-receptor antagonist TKA731 in painful diabetic neuropathy: A randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

The clinical picture of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

1 reference

7 January 2021

Mechanism-based pain diagnosis: issues for analgesic drug development

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Chronic pain and medullary descending facilitation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Descending modulation in persistent pain: an update

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Pain phenomena and possible mechanisms in patients with painful polyneuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Postherpetic neuralgia: irritable nociceptors and deafferentation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Cutaneous innervation density in the allodynic form of postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Capsaicin evoked pain and allodynia in post-herpetic neuralgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Painful neuropathy: altered central processing maintained dynamically by peripheral input

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Dynamic and static components of mechanical hyperalgesia in human hairy skin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Neuronal plasticity: increasing the gain in pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Somatosensory findings in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Mechanical allodynia in postherpetic neuralgia: evidence for central mechanisms depending on nociceptive C-fiber degeneration

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Chronic Deafferentation of Human Spinal Cord Neurons

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Supersensitivity to substance P after dorsal root section

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Chronic changes in the response of cells in adult cat dorsal horn following partial deafferentation: the appearance of responding cells in a previously non-responsive region

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Topical lidocaine reduces pain in post-herpetic neuralgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Topical lidocaine gel relieves postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Lamotrigine in spinal cord injury pain: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Complex regional pain syndrome--diagnostic, mechanisms, CNS involvement and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Intravenous phentolamine test: diagnostic and prognostic use in reflex sympathetic dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Intravenous subhypnotic propofol in central pain: a double-blind, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Changes in amino acid concentrations over time and space around an impact injury and their diffusion through the rat spinal cord

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Upregulation of Group I metabotropic glutamate receptors in neurons and astrocytes in the dorsal horn following spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Upregulation of Sodium Channel Nav1.3 and Functional Involvement in Neuronal Hyperexcitability Associated with Central Neuropathic Pain after Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0118

7 January 2021

Identifiers

DOI

10.1038/NCPNEURO0118

1 reference

15 August 2017

1 reference

PubMed ID

16932532